Munich - Delayed Quote EUR
Chimerix Inc (CXF.MU)
7.48
0.00
(0.00%)
As of April 17 at 5:27:07 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
212
212
324
33,824
1,979
Cost of Revenue
--
--
--
447
--
Gross Profit
212
212
324
33,377
1,979
Operating Expense
96,779
96,779
93,389
93,763
92,489
Operating Income
-96,567
-96,567
-93,065
-60,386
-90,510
Net Non Operating Interest Income Expense
8,180
8,180
10,970
2,919
164
Other Income Expense
--
--
--
229,670
-82,890
Pretax Income
-88,387
-88,387
-82,095
172,203
-173,236
Tax Provision
--
--
--
36
--
Net Income Common Stockholders
-88,387
-88,387
-82,095
172,167
-173,236
Diluted NI Available to Com Stockholders
-88,387
-88,387
-82,095
172,167
-173,236
Basic EPS
-0.94
-0.99
-0.93
1.97
-2.04
Diluted EPS
-0.94
-0.99
-0.93
1.94
-2.04
Basic Average Shares
89,376.68
89,699.07
88,604.03
87,555.11
84,930.26
Diluted Average Shares
89,376.68
89,699.07
88,604.03
88,776.15
84,930.26
Total Operating Income as Reported
-96,567
-96,567
-93,065
-60,386
-173,400
Total Expenses
96,779
96,779
93,389
94,210
92,489
Net Income from Continuing & Discontinued Operation
-88,387
-88,387
-82,095
172,167
-173,236
Normalized Income
-88,387
-88,387
-82,095
-57,454.99
-90,346
Interest Income
8,180
8,180
10,970
2,919
164
Net Interest Income
8,180
8,180
10,970
2,919
164
EBIT
-96,567
-96,567
-93,065
-60,386
-90,510
EBITDA
-96,473
-96,473
-92,974
-60,288
-90,343
Reconciled Cost of Revenue
--
--
--
447
--
Reconciled Depreciation
94
94
91
98
167
Net Income from Continuing Operation Net Minority Interest
-88,387
-88,387
-82,095
172,167
-173,236
Total Unusual Items Excluding Goodwill
--
--
--
229,670
-82,890
Total Unusual Items
--
--
--
229,670
-82,890
Normalized EBITDA
-96,473
-96,473
-92,974
-289,958
-7,453
Tax Rate for Calcs
--
--
--
0
--
Tax Effect of Unusual Items
--
--
--
48.01
--
12/31/2021 - 10/10/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1JK.SG Apellis Pharmaceuticals Inc
15.35
+0.70%
DR6.DU ACADIA Pharmaceuticals Inc
12.68
+3.05%
6XC.F Soleno Therapeutics, Inc.
57.90
0.00%
6XC.BE Soleno Therapeutics Inc
63.50
+1.76%
BH3.SG PTC Therapeutics Inc
42.20
+1.44%
DUL.SG Alnylam Pharmaceuticals Inc
209.20
+1.70%
L9S.F Gyre Therapeutics, Inc.
7.65
+5.52%
BH3.BE PTC Therapeutics Inc
43.20
+2.86%
41X.SG Ardelyx Inc
4.2200
+0.98%
ATQP.SG Vericel Corp
35.00
+1.16%